Atopic Dermatitis Systemic Therapies are topped by upadacitinib 30 mg in meta-analyses.

Published Date: 04 May 2023

Updated analysis of more than a dozen clinical trials evaluating upadacitinib as a monotherapy systemic treatment for atopic dermatitis reveals the drug's highly pervasive skin-clearing efficacy.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

2.

Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers

3.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

4.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

5.

WHO launches plan for free child cancer medicines


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot